RetaMaps

Rosalyn Crawford, M.D.

Rosalyn Crawford, M.D. · 14540 OLD SAINT AUGUSTINE RD STE 2201 · Jacksonville, FL 32258

4.0· 26 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss
  • Endocrine / metabolic care

About this practice

Rosalyn Crawford, M.D. is a physician in Jacksonville, Florida, listed for weight-loss care and endocrinology, with telehealth. The Baptist Health website linked to the listing says patients can choose a provider and then see available appointment dates and times to book online. Google shows a 4.0-star rating across 26 reviews dating back to 2016, with 1 in the past year; reviewers most often mention a caring manner and the physician's knowledge, and 2 mention results.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay accepted—
Accepts insurance — per practice website—
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.0
Google rating · 26 reviews
1
reviews in the past year (avg ★ 5.0)
1
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2025-09-29. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.0 across 26 Google reviews. Of the 26 reviews we analyzed, 19 (73%) are positive (4–5★) and 7 (27%) are negative (1–2★).

What patients like

  • Feeling listened to5 reviews
  • Knowledgeable, professional providers3 reviews
  • Friendly, helpful staff2 reviews

Common complaints

Very few complaints — only 7 negative reviews, with no recurring theme.

5★
19
4★
0
3★
0
2★
2
1★
5

Most recent Google reviews

Linda G.★★★★★2025-09-29

Dr Crawford is an amazing doctor, especially for women. She listens, she does not rush you out and I feel like she truly tries to understand your concerns.

Courtney H.★★★★★2024-09-09

Amazing. Dr Crawford was so kind. She covered every base with me took her time answered ever question ordered extra tests and walked me out. It’s rare you find a Dr so relatable on a human level. Absolutely loved her wish she was my everyday Dr.

K P.★★★★★2024-09-05

She was a nice enough doctor and did OK with treating thyroid, though she did question why my daughter and I were on T3 when we needed extra T3. But I knew that something was wrong with my daughter and the labs showed that something was VERY wrong and she wouldn't pull the trigger in order the test that we needed. So I moved on. If you need help with anything basic thyroid help and probably diabetes she's probably fine. But anything else, go elsewhere. It's so hard to get into this practice and get a hold of a live person to talk to you and then help you get isn't great.

Jean★★★★★2024-02-05

Typical of Baptist. The office is open. Once you make it thru the ARU. No one is available. I have a patient in the hospital just out of ICU that needs a specialist. The end of March (a 3 week wait) is not a good fit for someone who needs critical care.

Stephanie S.★★★★★2023-10-13

Dr. Crawford is an excellent doctor. She takes as much time as you need during your appointment and answers all of your questions. She never rushes you.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Rosalyn Crawford, M.D.

Nearby providers in Jacksonville

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs